Armata Pharmaceuticals Inc (ARMP)
2.36
+0.05
(+2.16%)
USD |
NYAM |
Nov 01, 16:00
Armata Pharmaceuticals Price to Book Value
Price to Book Value Chart
Historical Price to Book Value Data
Date | Value |
---|---|
September 29, 2023 | 5.662 |
September 28, 2023 | 5.322 |
September 27, 2023 | 5.303 |
September 26, 2023 | 5.039 |
September 25, 2023 | 5.001 |
September 22, 2023 | 5.058 |
September 21, 2023 | 5.001 |
September 20, 2023 | 5.153 |
September 19, 2023 | 5.322 |
September 18, 2023 | 5.511 |
September 15, 2023 | 5.096 |
September 14, 2023 | 5.530 |
September 13, 2023 | 5.265 |
September 12, 2023 | 5.624 |
September 11, 2023 | 5.737 |
September 08, 2023 | 5.624 |
September 07, 2023 | 5.775 |
September 06, 2023 | 5.850 |
September 05, 2023 | 6.039 |
September 01, 2023 | 6.058 |
August 31, 2023 | 6.530 |
August 30, 2023 | 6.605 |
August 29, 2023 | 5.888 |
August 28, 2023 | 5.473 |
August 25, 2023 | 5.530 |
Date | Value |
---|---|
August 24, 2023 | 5.492 |
August 23, 2023 | 5.662 |
August 22, 2023 | 5.190 |
August 21, 2023 | 6.813 |
August 18, 2023 | 6.718 |
August 17, 2023 | 7.436 |
August 16, 2023 | 7.568 |
August 15, 2023 | 8.115 |
August 14, 2023 | 7.851 |
August 11, 2023 | 8.210 |
August 10, 2023 | 7.624 |
August 09, 2023 | 7.322 |
August 08, 2023 | 7.209 |
August 07, 2023 | 6.737 |
August 04, 2023 | 7.285 |
August 03, 2023 | 6.964 |
August 02, 2023 | 6.209 |
August 01, 2023 | 4.831 |
July 31, 2023 | 4.699 |
July 28, 2023 | 4.605 |
July 27, 2023 | 4.699 |
July 26, 2023 | 5.171 |
July 25, 2023 | 3.718 |
July 24, 2023 | 2.963 |
July 21, 2023 | 2.170 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.7455
Minimum
Dec 28 2022
8.210
Maximum
Aug 11 2023
3.195
Average
2.695
Median
Jan 23 2023
Price to Book Value Benchmarks
AIM ImmunoTech Inc | 2.710 |
Perspective Therapeutics Inc | 2.391 |
Protalix BioTherapeutics Inc | 3.216 |
Electromed Inc | 4.441 |
Xtant Medical Holdings Inc | 1.639 |
Price to Book Value Related Metrics
PS Ratio | 854.52 |
Price | 2.36 |
Earnings Yield | -99.58% |
Market Cap | 85.39M |